Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

The efficacy and safety of thrombopoietin receptor agonists (TRAs) in older patients with primary immune thrombocytopenia (ITP) are unknown. We investigated TRA response and switch, thrombotic/hemorrhagic risk, and sustained responses off-treatment (SROTs) in 384 patients with ITP aged ≥60 years. Af...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-08, Vol.138 (7), p.571-583
Hauptverfasser:	Palandri, Francesca, Rossi, Elena, Bartoletti, Daniela, Ferretti, Antonietta, Ruggeri, Marco, Lucchini, Elisa, Carrai, Valentina, Barcellini, Wilma, Patriarca, Andrea, Rivolti, Elena, Consoli, Ugo, Cantoni, Silvia, Oliva, Esther Natalie, Chiurazzi, Federico, Caocci, Giovanni, Giuffrida, Gaetano, Borchiellini, Alessandra, Auteri, Giuseppe, Baldacci, Erminia, Carli, Giuseppe, Nicolosi, Daniela, Sutto, Emanuele, Carpenedo, Monica, Cavo, Michele, Mazzucconi, Maria Gabriella, Zaja, Francesco, De Stefano, Valerio, Rodeghiero, Francesco, Vianelli, Nicola
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!